Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock protein HSP90-beta (HSP90β) is a molecular chaperone encoded by the *HSP90AB1* gene. It assists in protein folding, refolding, and stabilization, and targets damaged proteins for degradation. It's essential for cellular proteostasis and is upregulated under stress. HSP90β supports multiple disease-relevant pathways, particularly in cancer, making it a target for drug development. However, clinical translation faces challenges due to toxicity and compensatory mechanisms.
Inhibition of ATP binding, leading to destabilization of client proteins and their subsequent degradation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein HSP90-beta (HSP90β).